Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol

被引：0

作者：

Trauth, Janina ^{[1
]}

Schuler, Rahel ^{[2
]}

Waitz, Markus ^{[2
]}

Ehrhardt, Harald ^{[2
,4
]}

Fritzenwanker, Moritz ^{[3
]}

Herold, Susanne ^{[1
]}

机构：

[1] Justus Liebig Univ, Dept Med Internal Med Infect Dis & Infect Control, Giessen, Germany

[2] Justus Liebig Univ, Dept Gen Pediat & Neonatol, Giessen, Germany

[3] Justus Liebig Univ Giessen, Inst Med Microbiol, Giessen, Germany

[4] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Div Neonatol & Pediat Intens Care Med, Ulm, Germany

来源：

INFECTION | 2024年

关键词：

Multi drug resistance; Stenotrophomonas maltophilia; Cefiderocol; Pneumogenic sepsis; Neonate;

D O I：

10.1007/s15010-024-02404-9

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Cefiderocol is a new siderophore-beta-lactam antibiotic used for the treatment of severe multidrug-resistant infections like sepsis, hospital-acquired and ventilator-associated pneumonia in adults, but there are only single reports on its use in the neonatal population. We describe the successful cefiderocol treatment of a newborn with pneumogenic sepsis due to Stenotrophomonas maltophilia.

引用

页数：4

共 50 条

[41] Effect of antibiotic therapy on the prognosis of ventilator-associated pneumonia caused by Stenotrophomonas maltophilia
Puech, Berenice
Canivet, Clemence
Teysseyre, Laura
Miltgen, Guillaume
Aujoulat, Thomas
Caron, Margot
Combe, Chloe
Jabot, Julien
Martinet, Olivier
Allyn, Jerome
Ferdynus, Cyril
Allou, Nicolas
ANNALS OF INTENSIVE CARE, 2021, 11 (01)
[42] Antimicrobial therapy for Stenotrophomonas maltophilia infections
Nicodemo, A. C.
Garcia Paez, J. I.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (04) : 229 - 237
[43] Haemorrhagic pneumonia caused by Stenotrophomonas maltophilia in two newborns
Guzoglu, Nilufer
Demirkol, Fatma N.
Aliefendioglu, Didem
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2015, 9 (05): : 533 - 535
[44] PNEUMONIA CAUSED BY STENOTROPHOMONAS-MALTOPHILIA WITH A MUCOID PHENOTYPE
IRIFUNE, K
ISHIDA, T
SHIMOGUCHI, K
OHTAKE, J
TANAKA, T
MORIKAWA, N
KAKU, M
KOGA, H
KOHNO, S
HARA, K
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (11) : 2856 - 2857
[45] Effect of antibiotic therapy on the prognosis of ventilator-associated pneumonia caused by Stenotrophomonas maltophilia
Bérénice Puech
Clémence Canivet
Laura Teysseyre
Guillaume Miltgen
Thomas Aujoulat
Margot Caron
Chloé Combe
Julien Jabot
Olivier Martinet
Jerome Allyn
Cyril Ferdynus
Nicolas Allou
Annals of Intensive Care, 11
[46] Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltration
Fratoni, Andrew J.
Kuti, Joseph L.
Nicolau, David P.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 (03)
[47] Tigecycline for Treatment of Nosocomial-Acquired Pneumonia Possibly Caused by Multi-Drug Resistant Strains of Stenotrophomonas maltophilia
Blanquer, D.
Otero, J. De
Padilla, E.
Gomez, F.
Mayol, A.
Irigaray, R.
Espejo, P.
Rada, M. A.
Makrantoni, G.
Perez, A. R.
JOURNAL OF CHEMOTHERAPY, 2008, 20 (06) : 761 - 763
[48] Nosocomial Stenotrophomonas maltophilia cross-infection:: Three cases in newborns
Gulcan, H
Kuzucu, C
Durmaz, R
AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (06) : 365 - 368
[49] The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen
Sanyal, SC
Mokaddas, EM
JOURNAL OF CHEMOTHERAPY, 1999, 11 (01) : 28 - 33
[50] Outbreak of nosocomial infection/colonisation caused by Stenotrophomonas maltophilia with mucoid phenotype
I Palabiyikoglu
M Tulunay
I Asik
M Oral
M Unsal
S Gungor
Critical Care, 3 (Suppl 1):

← 1 2 3 4 5 →